Outline
Denka Seiken Co., Ltd. is a publicly traded biomedical company founded in 1950 with its head office in Tokyo and manufacturing facilities in Niigata, Japan. We develop, manufacture and distribute high quality in vitro diagnostic reagents and vaccines. Top export products include direct and automatable HDL, LDL and sd-LDL reagents, latex-enhanced serum protein tests for hsCRP, rheumatoid factor, myglobin, ferritin and others. Rapid diagnostic test kits for MRSA, E. coli O157, parvo B19, norovirus and influenza viruses are also market leaders in many countries around the world. Denka Seiken possesses numerous collaborative business relations with world-wide top ten diagnostic companies, and has ISO 9001 and 14001 certification as well as a number of products FDA-cleared for sale in the US. More recently, the company has focused on contract R&D and manufacturing for immunochemistry products.
Denka Seiken established its first international branch office in the UK to assist in the promotion of its extensive line of diagnostics reagents for clinical chemistry and infectious disease testing. Recently the US branch office was established, complementing the UK office for promotional marketing activities, setting up of clinical trials and new product evaluations, and proving FDA-related regulatory support to the head office.
| Company Name | Denka Seiken Co., Ltd. |
|---|---|
| Head Office | Nihonbashi Mitsui Tower 1-1 Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo 103-8338, JAPAN |
| Establishment | February 11, 1950 |
| Paid-in Capital | 1,000 million YEN(JP) |
| Number of Employees (As of April 1, 2012) |
578 |
| Business | Production, sales and import and export of vaccines for human use, immunological, clinical chemical, bacteriological, and virological diagnostic reagents and food/environment testing reagents |
| Fiscal year ends | March |
| Board of Directors and Corporate Auditors: (As of April 1, 2012) | President and Representative Director: Shigetoshi Toyooka Senior Managing Director:Kiyomiki Kawanami Managing Director: Akira Fujiwara Managing Director: Yoshitaka Kubota Managing Director: Chikai Sato Director: Akira Obata Director: Hiroshi Adachi Director: Sakari Sekine Director: Tetsuro Maeda Director: Mitsukuni Ayabe Statutory Auditor: Takashi Fukuda Auditor: Tadashi Hashimoto Auditor: Hideo Oishi Auditor: Jiro Hiroe |
| Executive Officers: (As of April 1, 2012) | Senior Executive Officer: Masaru Hirano Senior Executive Officer: Kyouji Aoki Senior Executive Officer: Tsukasa Muramatsu Executive Officer: Yasuo Nakatomi |
| Offices | Factories: Niigata Plant, Kagamida Plant(Gosen-shi, Niigata) Branch Offices:Tokyo, Osaka Sales Offices:Sapporo, Sendai, Nagoya, Fukuoka |
| Subsidiaries | Denka Seiken UK Limited Denka Seiken USA Incorporated |
History
| 1950 | Feb. | The forerunner of Denka Seiken was established by Toshiba Corporation |
|---|---|---|
| 1952 | Sep. | Begins sales of bacteriological diagnostic reagents. |
| 1966 | May | Begins sales of virological diagnostic reagents |
| 1972 | Oct. | Begins sales of clinical chemstiry diagnostic reagents |
| 1979 | Jul. | Ownership changes to Denki Kagaku Kogyo KK |
| 1981 | Jan. | Begins sales of laboratory animal monitoring reagents |
| 1982 | Jan. | Changes name to Denka Seiken Co., Ltd. |
| 1986 | Oct. | Begins sales of immunochemistry serum protein diagnostic reagents |
| 1992 | Oct. | Begins sales of environmental and food hygiene monitoring line of contact agar plates |
| 1994 | Jan. | New Kamida facility built for clinical and immunochemistry reagent production |
| 1997 | Jun. | Begins sales of direct, automatable HDL reagent |
| 1998 | May | Obtains ISO 9001 certifcation |
| Sep. | Begins of sales of direct, automatable LDL reagent | |
| 1999 | Dec. | Offers its first IPO and is listed on JASDAQ |
| 2000 | June | Obtains ISO 14001 certification |
| Jul. | Begins sales of or rapid slide latex latex agglutination MRSA-Screen | |
| 2001 | Nov. | Begins sales of rapid POCT influenza test kit Influ A/B Quick |
| 2003 | April | Establishes Denka Seiken UK Limited |
| 2003 | July | Obtains ISO 13485 certification |
| 2004 | April | Establishes Denka Seiken USA Inc. |
| 2005 | July | Obtains CMDCAS certification |
| 2008 | Mar. | Delisting |
| 2008 | April | The Company became a wholly owned subsidiary of, Denki Kagaku Kogyo KK |